HENRY FAGNANT: Open Payments
NPI 1144811746 · LITTLETON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$995 in 46 payments from 13 companies in 2025. Trend: 2023 $1,611 · 2024 $2,025 · 2025 $995
Food & beverage: $995
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 8 | $167 |
| Vanda Pharmaceuticals Inc. | 4 | $105 |
| Otsuka America Pharmaceutical, Inc. | 4 | $101 |
| Collegium Pharmaceutical, Inc. | 6 | $97 |
| Tris Pharma Inc | 4 | $97 |
| ABBVIE INC. | 4 | $88 |
| Corium, LLC | 4 | $83 |
| Axsome Therapeutics, Inc. | 3 | $73 |
| Lundbeck LLC | 3 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $65 |
Products named: ARISTADA, REXULTI, FANAPT, Jornay PM, VRAYLAR, Azstarys, Auvelity, CAPLYTA.
Industry payments across CO — which companies pay providers there.
